Essure is a permanent, non-surgical transcervical sterilization procedure for women developed by Conceptus Inc. It was approved for use in the United States on November 4, 2002.[1] Two economic studies, one of which implemented Essure as an in-office procedure, suggest that Essure could be more cost-effective than laparoscopic bilateral tubal ligation.[2]
FRANKFURT, Germany — German drug company Bayer AG says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it offers.
Bayer said Monday it would launch a public offer to pay $31.00 per share for all the stock in Conceptus, Inc., which is based in Mountain View.
Conceptus makes Essure, an irreversible birth control method in which small metal and polyester coils are inserted to block a woman’s fallopian tubes. The procedure can be done in 10 minutes in a doctor’s office.
Bayer already markets birth control pills and intrauterine devices. CEO Marijn Dekkers said that the deal represented a “strategic bolt-on acquisition” and that it was an “excellent fit in the United States,
Short URL: http://www.newsnet14.com/?p=123735
3 comments:
Having Essure done was the single worst decision of my life. It meant I ended up having to have a total hysterectomy at 38 years old. It's just not worth it!
If you like your life and spending time with your children PLEASE So not do the essure !!!! Everything they say about this product is a joke and a lie !!!
This commercial is not completely truthful, why not share the serious adverse events. Bayer has been alerted to woman having issues with Essure, tell the truth
Post a Comment